Lie Sean sold $6.9M of CBRS

Lie Sean (Chief Technology Officer) sold 60,000 shares of Cerebras Systems Inc. (CBRS) at an average of $115.79 ($113.92–$116.82, $6.95M total) across 3 trades on 2026-10-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lie Sean
Published Oct 28, 2026, 10:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Bearish
medium confidence
Mentioned
$CBRS
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSBearishLow
01

Why it matters

The disclosed sale reduces insider ownership and may be interpreted as a bearish signal, though it follows a pre‑arranged 10b5‑1 plan.

02

Market read

Insider sell of $6.9M is material for short‑term traders monitoring CBRS.

03

What to watch

No immediate earnings or product news accompanies the filing; market may discount the sell.

Relevance 5/10Novelty 6/10Timing: after‑hours today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$CBRSBearishMedium confidence
Context

CTO Lie Sean sold 60,000 shares for $6.9M via a 10b5‑1 plan, reducing his stake to 263,592 shares.

Expected impact

likely pressure as the market prices in the insider sale

Evidence & confidence

A $6.9M sale by a senior officer is material and could prompt short‑term downside.

Market effects

Minimal impact on the AI‑hardware sector beyond Cerebras.

None

Limited to investors tracking insider activity.

Counterpoint

The sale may be routine under a pre‑arranged plan, not indicative of company outlook.

Key entities

  • Cerebras Systems Inc.

    AI‑chip maker listed on NASDAQ under ticker CBRS.

  • Lie Sean

    Chief Technology Officer of Cerebras, reporting the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Why Cerebras Systems Stock Is Plummeting Today

Cerebras Systems (CBRS) shares fell 9.2% after UBS cut its price target by 24% to $250, citing tempered expectations. Despite the reduction, UBS maintains a buy rating, noting potential upside from OpenAI demand and AWS adoption. The stock has also faced criticism from Culper Research, which took a short position. Cerebras is set to report Q3 earnings on Nov. 12.

$CBRSMed

Why is Cerebras Systems stock sliding today?

Cerebras Systems (CBRS) stock fell 8.3% to a 52-week low of $98.50 after UBS cut its price target to $250 from $330, citing reduced near-term conviction. The decline follows a short-seller report alleging chip degradation and upcoming share unlocks. The stock is down 70% from its high, but analysts maintain Buy ratings.

$CBRSHigh

Cerebras Stock Falls as Short Seller Questions Chip Lifespan

Cerebras Systems (CBRS) fell 5.77% after short seller Culper Research alleged its AI chips have a lifespan of 1.5 to 2.5 years and questioned its technology claims. Cerebras has not responded. The drop follows a lockup expiration and reverses part of a previous rally. The stock is far below its 52-week high of $386.34.

$CBRSHigh

Cerebras Gains 10% on Oracle Cloud Deal as “AI Inference Demands Choice”

Cerebras Systems (CBRS) shares rose 10% and Oracle (ORCL) gained 4% on Oct. 27 after Oracle announced plans to offer Cerebras' AI inference on its cloud starting in 2027. The deal aims to provide customers with more AI chip options. Analysts estimate Cerebras' 2027 revenue at $2.95 billion, though no deal value was disclosed. Cerebras trades at roughly half its average forward price/sales multiple since its IPO.

$CBRSMed

Why Cerebras Systems Stock Jumped on Tuesday

Cerebras Systems (CBRS) stock rose 10.1% after announcing a partnership with Oracle (ORCL) to offer its AI chip technology to Oracle Cloud Infrastructure customers. The company's Wafer-Scale Engine (WSE) is promoted for its large size and reduced latency. Cerebras reported a 287% year-over-year increase in cloud revenue to $128 million in Q2, but continues to incur losses.